English
简体中文
Total: £ 56.28
Published Date: 2025-08-22 | Pages: 114 | Tables: 112 | Medical Care
The global market for Laboratory-developed Testing was estimated to be worth US$ 3789 million in 2024 and is forecast to a readjusted size of US$ 4901 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.
While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.
The leading players in laboratory-developed testing include Quest Diagnostics, Roche, Illumina, Qiagen, and Eurofins, with the top three accounting for approximately 15% of the market.
North America is the largest market with more than 65% of the market, followed by Europe with about 15%.
This report aims to provide a comprehensive presentation of the global market for Laboratory-developed Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Laboratory-developed Testing by region & country, by Type, and by Application.
The Laboratory-developed Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Laboratory-developed Testing.
Market Segmentation
By Company
Adaptive Biotechnologies Corporation
Quest Diagnostics
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Biotheranostics
Adaptive Biotechnologies
Rosetta Genomics
Biodesix
Helix
Segment by Type
Commercial Service
R&D
Segment by Application
Genetic Testing
Oncology
Infectious Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Laboratory-developed Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Laboratory-developed Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Laboratory-developed Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Laboratory-developed Testing Product Introduction
1.2 Global Laboratory-developed Testing Market Size Forecast (2020-2031)
1.3 Laboratory-developed Testing Market Trends & Drivers
1.3.1 Laboratory-developed Testing Industry Trends
1.3.2 Laboratory-developed Testing Market Drivers & Opportunity
1.3.3 Laboratory-developed Testing Market Challenges
1.3.4 Laboratory-developed Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Laboratory-developed Testing Players Revenue Ranking (2024)
2.2 Global Laboratory-developed Testing Revenue by Company (2020-2025)
2.3 Key Companies Laboratory-developed Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Laboratory-developed Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Laboratory-developed Testing
2.6 Laboratory-developed Testing Market Competitive Analysis
2.6.1 Laboratory-developed Testing Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Laboratory-developed Testing Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Laboratory-developed Testing as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Commercial Service
3.1.2 R&D
3.2 Global Laboratory-developed Testing Sales Value by Type
3.2.1 Global Laboratory-developed Testing Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Laboratory-developed Testing Sales Value, by Type (2020-2031)
3.2.3 Global Laboratory-developed Testing Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Genetic Testing
4.1.2 Oncology
4.1.3 Infectious Disease
4.1.4 Others
4.2 Global Laboratory-developed Testing Sales Value by Application
4.2.1 Global Laboratory-developed Testing Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Laboratory-developed Testing Sales Value, by Application (2020-2031)
4.2.3 Global Laboratory-developed Testing Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Laboratory-developed Testing Sales Value by Region
5.1.1 Global Laboratory-developed Testing Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Laboratory-developed Testing Sales Value by Region (2020-2025)
5.1.3 Global Laboratory-developed Testing Sales Value by Region (2026-2031)
5.1.4 Global Laboratory-developed Testing Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Laboratory-developed Testing Sales Value, 2020-2031
5.2.2 North America Laboratory-developed Testing Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Laboratory-developed Testing Sales Value, 2020-2031
5.3.2 Europe Laboratory-developed Testing Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Laboratory-developed Testing Sales Value, 2020-2031
5.4.2 Asia Pacific Laboratory-developed Testing Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Laboratory-developed Testing Sales Value, 2020-2031
5.5.2 South America Laboratory-developed Testing Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Laboratory-developed Testing Sales Value, 2020-2031
5.6.2 Middle East & Africa Laboratory-developed Testing Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Laboratory-developed Testing Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Laboratory-developed Testing Sales Value, 2020-2031
6.3 United States
6.3.1 United States Laboratory-developed Testing Sales Value, 2020-2031
6.3.2 United States Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Laboratory-developed Testing Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Laboratory-developed Testing Sales Value, 2020-2031
6.4.2 Europe Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Laboratory-developed Testing Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Laboratory-developed Testing Sales Value, 2020-2031
6.5.2 China Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
6.5.3 China Laboratory-developed Testing Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Laboratory-developed Testing Sales Value, 2020-2031
6.6.2 Japan Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Laboratory-developed Testing Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Laboratory-developed Testing Sales Value, 2020-2031
6.7.2 South Korea Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Laboratory-developed Testing Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Laboratory-developed Testing Sales Value, 2020-2031
6.8.2 Southeast Asia Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Laboratory-developed Testing Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Laboratory-developed Testing Sales Value, 2020-2031
6.9.2 India Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
6.9.3 India Laboratory-developed Testing Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Adaptive Biotechnologies Corporation
7.1.1 Adaptive Biotechnologies Corporation Profile
7.1.2 Adaptive Biotechnologies Corporation Main Business
7.1.3 Adaptive Biotechnologies Corporation Laboratory-developed Testing Products, Services and Solutions
7.1.4 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.1.5 Adaptive Biotechnologies Corporation Recent Developments
7.2 Quest Diagnostics
7.2.1 Quest Diagnostics Profile
7.2.2 Quest Diagnostics Main Business
7.2.3 Quest Diagnostics Laboratory-developed Testing Products, Services and Solutions
7.2.4 Quest Diagnostics Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.2.5 Quest Diagnostics Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Laboratory-developed Testing Products, Services and Solutions
7.3.4 Roche Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.3.5 Roche Recent Developments
7.4 Illumina
7.4.1 Illumina Profile
7.4.2 Illumina Main Business
7.4.3 Illumina Laboratory-developed Testing Products, Services and Solutions
7.4.4 Illumina Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.4.5 Illumina Recent Developments
7.5 Qiagen
7.5.1 Qiagen Profile
7.5.2 Qiagen Main Business
7.5.3 Qiagen Laboratory-developed Testing Products, Services and Solutions
7.5.4 Qiagen Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.5.5 Qiagen Recent Developments
7.6 Eurofins
7.6.1 Eurofins Profile
7.6.2 Eurofins Main Business
7.6.3 Eurofins Laboratory-developed Testing Products, Services and Solutions
7.6.4 Eurofins Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.6.5 Eurofins Recent Developments
7.7 Guardant Health
7.7.1 Guardant Health Profile
7.7.2 Guardant Health Main Business
7.7.3 Guardant Health Laboratory-developed Testing Products, Services and Solutions
7.7.4 Guardant Health Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.7.5 Guardant Health Recent Developments
7.8 Biotheranostics
7.8.1 Biotheranostics Profile
7.8.2 Biotheranostics Main Business
7.8.3 Biotheranostics Laboratory-developed Testing Products, Services and Solutions
7.8.4 Biotheranostics Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.8.5 Biotheranostics Recent Developments
7.9 Adaptive Biotechnologies
7.9.1 Adaptive Biotechnologies Profile
7.9.2 Adaptive Biotechnologies Main Business
7.9.3 Adaptive Biotechnologies Laboratory-developed Testing Products, Services and Solutions
7.9.4 Adaptive Biotechnologies Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.9.5 Adaptive Biotechnologies Recent Developments
7.10 Rosetta Genomics
7.10.1 Rosetta Genomics Profile
7.10.2 Rosetta Genomics Main Business
7.10.3 Rosetta Genomics Laboratory-developed Testing Products, Services and Solutions
7.10.4 Rosetta Genomics Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.10.5 Rosetta Genomics Recent Developments
7.11 Biodesix
7.11.1 Biodesix Profile
7.11.2 Biodesix Main Business
7.11.3 Biodesix Laboratory-developed Testing Products, Services and Solutions
7.11.4 Biodesix Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.11.5 Biodesix Recent Developments
7.12 Helix
7.12.1 Helix Profile
7.12.2 Helix Main Business
7.12.3 Helix Laboratory-developed Testing Products, Services and Solutions
7.12.4 Helix Laboratory-developed Testing Revenue (US$ Million) & (2020-2025)
7.12.5 Helix Recent Developments
8 Industry Chain Analysis
8.1 Laboratory-developed Testing Industrial Chain
8.2 Laboratory-developed Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Laboratory-developed Testing Sales Model
8.5.2 Sales Channel
8.5.3 Laboratory-developed Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Laboratory-developed Testing Market Trends
Table 2. Laboratory-developed Testing Market Drivers & Opportunity
Table 3. Laboratory-developed Testing Market Challenges
Table 4. Laboratory-developed Testing Market Restraints
Table 5. Global Laboratory-developed Testing Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Laboratory-developed Testing Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Laboratory-developed Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Laboratory-developed Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Laboratory-developed Testing
Table 10. Global Laboratory-developed Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Laboratory-developed Testing as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Laboratory-developed Testing Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Laboratory-developed Testing Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Laboratory-developed Testing Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Laboratory-developed Testing Sales Market Share in Value by Type (2020-2025)
Table 17. Global Laboratory-developed Testing Sales Market Share in Value by Type (2026-2031)
Table 18. Global Laboratory-developed Testing Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Laboratory-developed Testing Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Laboratory-developed Testing Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Laboratory-developed Testing Sales Market Share in Value by Application (2020-2025)
Table 22. Global Laboratory-developed Testing Sales Market Share in Value by Application (2026-2031)
Table 23. Global Laboratory-developed Testing Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Laboratory-developed Testing Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Laboratory-developed Testing Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Laboratory-developed Testing Sales Value by Region (2020-2025) & (%)
Table 27. Global Laboratory-developed Testing Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Laboratory-developed Testing Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Laboratory-developed Testing Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Laboratory-developed Testing Sales Value, (2026-2031) & (US$ Million)
Table 31. Adaptive Biotechnologies Corporation Basic Information List
Table 32. Adaptive Biotechnologies Corporation Description and Business Overview
Table 33. Adaptive Biotechnologies Corporation Laboratory-developed Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Laboratory-developed Testing Business of Adaptive Biotechnologies Corporation (2020-2025)
Table 35. Adaptive Biotechnologies Corporation Recent Developments
Table 36. Quest Diagnostics Basic Information List
Table 37. Quest Diagnostics Description and Business Overview
Table 38. Quest Diagnostics Laboratory-developed Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Laboratory-developed Testing Business of Quest Diagnostics (2020-2025)
Table 40. Quest Diagnostics Recent Developments
Table 41. Roche Basic Information List
Table 42. Roche Description and Business Overview
Table 43. Roche Laboratory-developed Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Laboratory-developed Testing Business of Roche (2020-2025)
Table 45. Roche Recent Developments
Table 46. Illumina Basic Information List
Table 47. Illumina Description and Business Overview
Table 48. Illumina Laboratory-developed Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Laboratory-developed Testing Business of Illumina (2020-2025)
Table 50. Illumina Recent Developments
Table 51. Qiagen Basic Information List
Table 52. Qiagen Description and Business Overview
Table 53. Qiagen Laboratory-developed Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Laboratory-developed Testing Business of Qiagen (2020-2025)
Table 55. Qiagen Recent Developments
Table 56. Eurofins Basic Information List
Table 57. Eurofins Description and Business Overview
Table 58. Eurofins Laboratory-developed Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Laboratory-developed Testing Business of Eurofins (2020-2025)
Table 60. Eurofins Recent Developments
Table 61. Guardant Health Basic Information List
Table 62. Guardant Health Description and Business Overview
Table 63. Guardant Health Laboratory-developed Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Laboratory-developed Testing Business of Guardant Health (2020-2025)
Table 65. Guardant Health Recent Developments
Table 66. Biotheranostics Basic Information List
Table 67. Biotheranostics Description and Business Overview
Table 68. Biotheranostics Laboratory-developed Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Laboratory-developed Testing Business of Biotheranostics (2020-2025)
Table 70. Biotheranostics Recent Developments
Table 71. Adaptive Biotechnologies Basic Information List
Table 72. Adaptive Biotechnologies Description and Business Overview
Table 73. Adaptive Biotechnologies Laboratory-developed Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Laboratory-developed Testing Business of Adaptive Biotechnologies (2020-2025)
Table 75. Adaptive Biotechnologies Recent Developments
Table 76. Rosetta Genomics Basic Information List
Table 77. Rosetta Genomics Description and Business Overview
Table 78. Rosetta Genomics Laboratory-developed Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Laboratory-developed Testing Business of Rosetta Genomics (2020-2025)
Table 80. Rosetta Genomics Recent Developments
Table 81. Biodesix Basic Information List
Table 82. Biodesix Description and Business Overview
Table 83. Biodesix Laboratory-developed Testing Products, Services and Solutions
Table 84. Revenue (US$ Million) in Laboratory-developed Testing Business of Biodesix (2020-2025)
Table 85. Biodesix Recent Developments
Table 86. Helix Basic Information List
Table 87. Helix Description and Business Overview
Table 88. Helix Laboratory-developed Testing Products, Services and Solutions
Table 89. Revenue (US$ Million) in Laboratory-developed Testing Business of Helix (2020-2025)
Table 90. Helix Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Laboratory-developed Testing Downstream Customers
Table 94. Laboratory-developed Testing Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Laboratory-developed Testing Product Picture
Figure 2. Global Laboratory-developed Testing Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Laboratory-developed Testing Sales Value (2020-2031) & (US$ Million)
Figure 4. Laboratory-developed Testing Report Years Considered
Figure 5. Global Laboratory-developed Testing Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Laboratory-developed Testing Revenue in 2024
Figure 7. Laboratory-developed Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Commercial Service Picture
Figure 9. R&D Picture
Figure 10. Global Laboratory-developed Testing Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global Laboratory-developed Testing Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Genetic Testing
Figure 13. Product Picture of Oncology
Figure 14. Product Picture of Infectious Disease
Figure 15. Product Picture of Others
Figure 16. Global Laboratory-developed Testing Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Laboratory-developed Testing Sales Value Market Share by Application, 2024 & 2031
Figure 18. North America Laboratory-developed Testing Sales Value (2020-2031) & (US$ Million)
Figure 19. North America Laboratory-developed Testing Sales Value by Country (%), 2024 VS 2031
Figure 20. Europe Laboratory-developed Testing Sales Value, (2020-2031) & (US$ Million)
Figure 21. Europe Laboratory-developed Testing Sales Value by Country (%), 2024 VS 2031
Figure 22. Asia Pacific Laboratory-developed Testing Sales Value, (2020-2031) & (US$ Million)
Figure 23. Asia Pacific Laboratory-developed Testing Sales Value by Region (%), 2024 VS 2031
Figure 24. South America Laboratory-developed Testing Sales Value, (2020-2031) & (US$ Million)
Figure 25. South America Laboratory-developed Testing Sales Value by Country (%), 2024 VS 2031
Figure 26. Middle East & Africa Laboratory-developed Testing Sales Value, (2020-2031) & (US$ Million)
Figure 27. Middle East & Africa Laboratory-developed Testing Sales Value by Country (%), 2024 VS 2031
Figure 28. Key Countries/Regions Laboratory-developed Testing Sales Value (%), (2020-2031)
Figure 29. United States Laboratory-developed Testing Sales Value, (2020-2031) & (US$ Million)
Figure 30. United States Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
Figure 31. United States Laboratory-developed Testing Sales Value by Application (%), 2024 VS 2031
Figure 32. Europe Laboratory-developed Testing Sales Value, (2020-2031) & (US$ Million)
Figure 33. Europe Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
Figure 34. Europe Laboratory-developed Testing Sales Value by Application (%), 2024 VS 2031
Figure 35. China Laboratory-developed Testing Sales Value, (2020-2031) & (US$ Million)
Figure 36. China Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
Figure 37. China Laboratory-developed Testing Sales Value by Application (%), 2024 VS 2031
Figure 38. Japan Laboratory-developed Testing Sales Value, (2020-2031) & (US$ Million)
Figure 39. Japan Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
Figure 40. Japan Laboratory-developed Testing Sales Value by Application (%), 2024 VS 2031
Figure 41. South Korea Laboratory-developed Testing Sales Value, (2020-2031) & (US$ Million)
Figure 42. South Korea Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
Figure 43. South Korea Laboratory-developed Testing Sales Value by Application (%), 2024 VS 2031
Figure 44. Southeast Asia Laboratory-developed Testing Sales Value, (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
Figure 46. Southeast Asia Laboratory-developed Testing Sales Value by Application (%), 2024 VS 2031
Figure 47. India Laboratory-developed Testing Sales Value, (2020-2031) & (US$ Million)
Figure 48. India Laboratory-developed Testing Sales Value by Type (%), 2024 VS 2031
Figure 49. India Laboratory-developed Testing Sales Value by Application (%), 2024 VS 2031
Figure 50. Laboratory-developed Testing Industrial Chain
Figure 51. Laboratory-developed Testing Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
